LPCAT1 and hepatocellular carcinoma: Moreover, several therapeutic drugs were successfully predicted by targeting at the genetic regulatory network of LPCAT1. As is known, the clinical efficiency of HCC patients was largely limited by chemotherapy resistance and liver dysfunction.